Evidence map›Paper›PMID 33417940›Full record

ReviewGastroenterology2021

An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer.

Andrea N Burnett-Hartman, Jeffrey K Lee, Joshua Demb, Samir Gupta

Abstract readReview
In one paragraph

Review in Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 162 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Positive Predictive Value of Symptoms for Early-Onset Colorectal Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrea N Burnett-HartmanInstitute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado. Electronic address: Andrea.N.Burnett-Hartman@kp.org.
Jeffrey K LeeDivision of Research, Kaiser Permanente Northern California; Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California. Electronic address: s1gupta@health.ucsd.edu.
Joshua DembDivision of Gastroenterology, Department of Internal Medicine, University of California, San Diego, La Jolla, California.
Samir GuptaDivision of Gastroenterology, Department of Internal Medicine, University of California, San Diego, La Jolla, California; VA San Diego Healthcare System, San Diego, California.

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Nodora · 1985 to 2026
$124.9M
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)U24CA221936 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LI, CHRISTOPHER I, ZHENG, YINGYE · 2018 to 2023
$5.7M
CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers.UH3CA233314 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUPTA, SAMIR, HILL, LINDA L · 2020 to 2023
$4.9M
Serrated Colorectal Cancer: An Emerging Disease Subtype (Admin Supplement)R01CA196337 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PHIPPS, AMANDA IRENE · 2015 to 2020
$3.7M
Post-polypectomy Surveillance for Reducing Colon Cancer Incidence and MortalityR37CA222866 · NCI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GUPTA, SAMIR · 2018 to 2023
$3.3M
Optimizing long-term post-polypectomy surveillance for colorectal cancer prevention using a prediction rule developed from a large, community-based cohortK07CA212057 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEE, JEFFREY KUANG ZOU · 2016 to 2020
$869k
CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers.UG3CA233314 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CASTANEDA, SHEILA FAYE, GUPTA, SAMIR · 2019 to 2019
$604k
Colonoscopy in young onset colorectal cancerF32CA239360 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEMB, JOSHUA BRIAN · 2019 to 2022
$227k
NCI NIH HHS F32 CA239360NCI NIH HHS K07 CA212057NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA196337NCI NIH HHS R37 CA222866NCI NIH HHS U24 CA221936NCI NIH HHS UG3 CA233314NCI NIH HHS UH3 CA233314
6 · The paper itself

Abstract

Rising trends in the incidence and mortality of early-onset colorectal cancer (CRC) in those who are younger than 50 years have been well established. These trends have spurred intense investigation focused on elucidating the epidemiology and characteristics of early-onset CRC, as well as on identifying strategies for early detection and prevention. In this review, we provide a contemporary update on early-onset CRC with a particular focus on epidemiology, molecular characterization, red flag signs and symptoms, and screening for early-onset CRC.

Indexed as

Age of OnsetBiomarkers, TumorColorectal NeoplasmsEarly Detection of CancerHumansMass ScreeningMicrosatellite InstabilityPractice Guidelines as TopicPrecision MedicineRisk FactorsTriageBiomarkers, TumorEarly-Onset Colorectal CancerEpidemiologyRed Flags

Identifiers

PMID33417940
PMCPMC8273929

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.